Skip to main content
# Title Research Member Research Year
1 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Amira Emad Mohamed Elwy 2025
2 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2025
3 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Dr. Shimaa Hassan Shabaan Hassan 2025
4 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Amira Emad Mohamed Elwy 2024
5 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2024
6 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Dr. Shimaa Hassan Shabaan Hassan 2024
7 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Dr. Marwa Tammam Ameen Hammam 2022
8 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Dr. Hanaan Ahmed Mohammed Ahmed 2022
9 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Prof. Eman Massad Zaki El-Hefny 2022
10 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Israa Mostafa Kamal Mohammed 2022